Townsend & Associates’s General Moly, Inc. GMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5,470
Closed -$2K 184
2018
Q1
$2K Hold
5,470
﹤0.01% 156
2017
Q4
$2K Buy
+5,470
New +$1.74K ﹤0.01% 182

Other funds holding GMO

Townsend & Associates's GMO Position: Q2 2018 in Review

Townsend & Associates sold out of General Moly, Inc. (GMO) in Q2 2018, closing a stake of 5,470 shares — an estimated $2K sold.

Townsend & Associates first reported a position in GMO in Q4 2017 and held it in 2 quarters. The position peaked at $2K in Q1 2018. 41 funds tracked by Wall St. Rank hold GMO as of Q2 2018.

  • Townsend & Associates reported no remaining General Moly, Inc. position as of Q2 2018 after selling out during the quarter.
  • Townsend & Associates sold 5,470 General Moly, Inc. shares in Q2 2018, an estimated $2K.
  • Townsend & Associates first reported a position in General Moly, Inc. in Q4 2017 and held it in 2 quarters.
  • Townsend & Associates's General Moly, Inc. position peaked at $2K in Q1 2018.
  • 41 funds tracked by Wall St. Rank held General Moly, Inc. as of Q2 2018.

Based on Townsend & Associates's 13F filing for Q2 2018, filed 19 Jul 2018.